• SOLITOMAB chembl:CHEMBL2109264 Antineoplastic

    Alternate Names:

    MT110
    SOLITOMAB

    Drug Info:

    FDA Approval not approved
    Drug Class antibody
    Drug Indications antineoplastic agent
    (0 More Sources)

    Publications:

  • Interaction Score: 3.99

    Interaction Types & Directionality:
    antibody (inhibitory)

    Interaction Info:
    Notes
    Trial Name MT110
    Novel drug target Novel Target

    PMIDs:
    None found


  • Interaction Score: 2.28

    Interaction Types & Directionality:
    n/a

    Interaction Info:
    Trial Name MT110
    Novel drug target Established target

    PMIDs:
    None found


    Sources:
    TdgClinicalTrial

  • Interaction Score: 1.59

    Interaction Types & Directionality:
    n/a

    Interaction Info:
    Novel drug target Established target
    Trial Name MT110

    PMIDs:
    None found


    Sources:
    TdgClinicalTrial

  • Interaction Score: 1.23

    Interaction Types & Directionality:
    n/a

    Interaction Info:
    Trial Name MT110
    Novel drug target Established target

    PMIDs:
    None found


    Sources:
    TdgClinicalTrial

    • Version: January-2014

    Alternate Names:

    Drug Info:
    Drug Indications antineoplastic agent
    Drug Class antibody
    FDA Approval not approved

    Publications:

    • Version: 12-May-2016

    Alternate Names:
    MT110 Drug Synonym
    MT110 Primary Drug Name

    Drug Info:

    Publications:

    • Version: ChEMBL_27

    Alternate Names:

    Drug Info:

    Publications: